// App-Quantinova.ai

TPS5092 : Intense exercise for survival among men with metastatic castrate-resistant prostate cancer (INTERVAL MCRPC): A Movember funded multicenter, randomized, controlled phase III study.

Researchers

Presenter

  • Fred Saad

Principal Investigators

  • June M. Chan

  • Nicolas H. Hart

  • Kerry S. Courneya

  • James Catto

  • Stephen P. Finn

  • Rosemary Greenwood

  • Daniel C Hughes

  • Lorelei A. Mucci

  • Stephen R Plymate

  • Michael N. Pollak

  • Stephan F.E. Praet

  • Aaron P. Russell

  • Emer M. Guinan

  • Erin Van Blarigan

  • Orla Casey

  • Mark Buzza

  • Charles J. Ryan

  • Robert Usher Newton

Medical Centers

  • University of Montreal, Montreal, QC, Canada

  • University of California, San Francisco, San Francisco, CA

  • Exercise Medicine Research Institute, Edith Cowan University, Perth, Australia

  • University of Alberta, Edmonton, AB, Canada

  • University of Sheffield, Sheffield, United Kingdom

  • University College Dublin, Dublin 4, Ireland

  • University Hospitals Bristol NHS Foundation Trust, Wells Somerset, United Kingdom

  • University of Texas Health Science Center San Antonio, San Antonio, TX

  • Harvard School of Public Health, Boston, MA

  • University of Washington, Seattle, WA

  • Jewish General Hospital, Montreal, QC, Canada

  • Australian Institute of Sport, Canberra, Australia

  • Deakin University, Melbourne, Australia

  • Movember Foundation, Melbourne, Australia

  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Locations

  • Canada

  • Ireland

  • United Kingdom

  • Australia

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • Enzalutamide

  • CB-7598

  • Androgen Tear

  • Opiate

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

  • Prospective

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved